Peter F. Zeng

Department Of Otolaryngology Head And Neck Surgery
London, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Awake Blue Light vs. KTP Laser Treatment for Vocal Fold Lesions: A Randomized Controlled Trial.

Awake Blue Light vs. KTP Laser Treatment for Vocal Fold Lesions: A Randomized Controlled Trial.

Journal: The Laryngoscope

Published: February 27, 2026

Understanding and overcoming innate and acquired MAPK inhibition resistance in anaplastic thyroid cancer.

Understanding and overcoming innate and acquired MAPK inhibition resistance in anaplastic thyroid cancer.

Journal: Cell reports. Medicine

Published: January 15, 2025

Transcriptomic Features of Recurrence Rates in Idiopathic Subglottic Stenosis.

Transcriptomic Features of Recurrence Rates in Idiopathic Subglottic Stenosis.

Journal: The Laryngoscope

Published: December 13, 2024

Effect of Serial Intralesional Steroid Injections on Risk of Recurrence in Idiopathic Subglottic Stenosis.

Effect of Serial Intralesional Steroid Injections on Risk of Recurrence in Idiopathic Subglottic Stenosis.

Journal: The Laryngoscope

Published: December 13, 2024

Molecular features of T and N stage progression in laryngeal cancer.

Molecular features of T and N stage progression in laryngeal cancer.

Journal: Oral oncology

Published: November 03, 2024

Cohort-level clinical trajectory and molecular landscape of idiopathic subglottic stenosis for precision laryngology-a study of the Canadian Airways Research (CARE) group.

Cohort-level clinical trajectory and molecular landscape of idiopathic subglottic stenosis for precision laryngology-a study of the Canadian Airways Research (CARE) group.

Journal: EBioMedicine

Published: June 21, 2024

Cellular blueprint of healthy and diseased human epiglottis and subglottis-a study of the Canadian Airways Research (CARE) group.

Cellular blueprint of healthy and diseased human epiglottis and subglottis-a study of the Canadian Airways Research (CARE) group.

Journal: EBioMedicine

Published: June 21, 2024

Loss of MACROD2 drives radioresistance but not cisplatin resistance in HPV-positive head and neck cancer.

Loss of MACROD2 drives radioresistance but not cisplatin resistance in HPV-positive head and neck cancer.

Journal: Oral oncology

Published: June 14, 2024

Clinical Presentation and Genomic Analysis of HPV-Related Squamous Cell Carcinoma of the Larynx in Two Young Female Patients.

Clinical Presentation and Genomic Analysis of HPV-Related Squamous Cell Carcinoma of the Larynx in Two Young Female Patients.

Journal: Cureus

Published: November 02, 2023

HPV16 Intratypic Variants in Head and Neck Cancers: A North American Perspective.

HPV16 Intratypic Variants in Head and Neck Cancers: A North American Perspective.

Journal: Viruses

Published: November 01, 2023

Metabolic pathway-based subtypes associate glycan biosynthesis and treatment response in head and neck cancer.

Metabolic pathway-based subtypes associate glycan biosynthesis and treatment response in head and neck cancer.

Journal: NPJ precision oncology

Published: August 10, 2023

A comparison of timing and patterns of treatment failure, and survival outcomes after progression between HPV+ and HPV- patients undergoing chemoradiation for oropharyngeal squamous cell carcinomas.

A comparison of timing and patterns of treatment failure, and survival outcomes after progression between HPV+ and HPV- patients undergoing chemoradiation for oropharyngeal squamous cell carcinomas.

Journal: Head & neck

Published: April 16, 2023

Showing 1-12 of 28

Last Updated: 09/26/2026